Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Read More
Merck snags Chinese obesity drug in nearly $2 billion deal
Estimated read time
1 min read
You May Also Like
Gazprom Expects Revenue From Gas Sales to Beat Plan This Year
December 24, 2024
American Airlines temporarily grounded flights due to technical glitch
December 24, 2024
More From Author
Gazprom Expects Revenue From Gas Sales to Beat Plan This Year
December 24, 2024
Apple TV Plus: the best shows from 2024
December 24, 2024
+ There are no comments
Add yours